Why stability matters

Peptides are fragile. Unlike a lot of small-molecule compounds, they're vulnerable to a handful of degradation pathways that can quietly wreck a sample without any visible change — no color shift, no smell, nothing. A degraded peptide doesn't just fail to do what it's supposed to do; it can produce artifactual results that contaminate your whole dataset and you won't know until something looks wrong.

Degradation shows up three ways: chemical breakdown of the backbone (hydrolysis, oxidation of methionine/tryptophan/cysteine, deamidation), physical instability like aggregation that quietly drops your effective concentration, and microbial contamination, which introduces enzymatic cleavage that can take a compound apart fast.

The three things that actually destroy a peptide

Temperature

Temperature is the best-characterized driver of degradation. Roughly speaking, every 10°C increase doubles the rate of most chemical reactions — including the ones you don't want. A peptide left at room temperature degrades about 32x faster than one stored at −20°C, and roughly 1,000x faster than one kept at −80°C.

Cycling — repeatedly warming and re-freezing — is often worse than just sitting at a slightly elevated temperature. Every freeze-thaw cycle stresses the lyophilized structure and exposes reactive sites to oxidation during the thaw. Aliquot on arrival so you're never cracking open the main stock vial.

Moisture

Lyophilized peptides are formulated to have very low water content — usually under 1% by mass — to limit hydrolysis and molecular movement inside the dried matrix. Even a few seconds of exposure to humid air above 30% RH can meaningfully raise moisture content, which accelerates hydrolysis and drops the glass transition temperature of the matrix.

Let sealed vials warm to room temperature before opening — opening a cold vial invites condensation straight into the product. Work fast, work clean, reseal with desiccant where you can.

Light

Tryptophan, tyrosine, phenylalanine, and methionine residues are photosensitive. UV (and to a lesser degree, visible light) can kick off free-radical oxidation that changes the compound's mass and activity. Store in amber vials, keep handling time under bright lab lighting short.

Storage by timeframe

The workflow that actually works

• Aliquot on arrival. Split stock into single-use portions before anything else touches storage.
• Label with receipt date and lot number. You'll want this if a result looks off six weeks later.
• Use inert headspace where you can. Nitrogen or argon stops oxygen-driven oxidation — critical for cysteine-containing peptides.
• Equilibrate before opening. Always.
• Re-check purity periodically on long-running work to confirm stored material is still in spec.

What a COA actually is

A Certificate of Analysis is a lab report. It states what was tested, the method used, and the result — identity confirmation, purity percentage, residual solvents, heavy metals, sometimes endotoxin or microbial load. That's it. It's not a marketing asset, and it shouldn't be treated like one. A COA that's just a logo and a "PASS" stamp with no method listed isn't a COA, it's a screenshot.

The part most buyers skip: who ran the test and when it was run matters as much as the result. Old, recycled, or generic COAs can create unsupported confidence. A useful document should name the lab, method, lot, and date clearly.

Purity: the headline number

Purity is almost always reported via reverse-phase HPLC (RP-HPLC), area-normalized — meaning the area under your peptide's peak is divided by the total area under all peaks in the run, related compounds included. A 99.1% purity result means 99.1% of everything detected in that sample was your target peptide; the rest is truncated sequences, deletion products, or synthesis byproducts.

Purity alone doesn't confirm identity — a sample can be "99% pure" and still be the wrong molecule if synthesis went wrong from the start. That's why a real COA pairs HPLC purity with mass spectrometry.

Identity: what mass spec confirms

Mass spectrometry measures the molecular weight of the sample and compares it against the expected mass of the target sequence. This is what actually confirms you're holding the compound the label says you are, not just "something mostly pure." Skip this step and a vendor can sell you a clean-looking peak that isn't the peptide at all.

What else should be on it

• Lot / batch number — ties the COA to a specific production run, not a generic "this is what we usually get" claim.
• Testing lab name and method — if it's not named, you can't verify it.
• Test date — old COAs get reused across new batches more often than you'd think.
• Residual solvents and heavy metals — synthesis byproducts that don't show up on a purity peak.

How to read one before you buy

Check the lot number against what's actually being shipped. Confirm the testing lab is named and searchable. Look for both purity and identity confirmation — one without the other is half a result. And check the date; a COA from eight months ago tells you nothing about the batch in front of you now.

What reconstitution actually does

Lyophilization removes water under vacuum, leaving a porous, amorphous solid that's far more stable than a liquid solution. Reconstitution reverses that — solvent re-hydrates the matrix and the peptide goes back into solution. It sounds simple. The failure modes aren't.

Adding solvent too fast, hitting the cake at the wrong angle, or using the wrong solvent for a hydrophobic sequence can cause local concentration spikes, foaming, or incomplete dissolution — any of which can denature or aggregate peptide before you've even started your work.

Before you reconstitute

Let the vial reach room temperature before opening — this is the single most-skipped step, and it's the one that introduces condensation directly into your dry product. Inspect the cake: a collapsed or discolored cake can indicate prior temperature excursions during shipping or storage, even if the vial looks sealed.

Picking a solvent

Bacteriostatic water (with 0.9% benzyl alcohol) is the standard default for most research peptides and adds a degree of antimicrobial protection for multi-use vials. For acidic or hydrophobic sequences that won't fully dissolve in plain water, a small volume of dilute acetic acid or a small percentage of DMSO is sometimes used as a pre-solvent, followed by dilution. Get the solvent choice wrong for the peptide's character and you'll get visible precipitation or a falsely low effective concentration with no visible warning sign.

Technique

Add solvent slowly, down the inside wall of the vial — never a direct stream onto the lyophilized cake. Swirl gently; don't shake. Vigorous agitation introduces shear stress and can denature the peptide structure, especially for longer sequences. Let the cake fully dissolve before drawing any volume — partial dissolution means your concentration math is wrong from the first draw.

After reconstitution

Once in solution, the clock changes. Reconstituted peptides are far less stable than lyophilized stock and generally should be refrigerated and used within a defined window — guidance varies by sequence, but treating reconstituted solution as a short-term working stock rather than long-term storage is the safer default. Label the vial with reconstitution date and concentration; "I'll remember" is not a documentation method.

Defining purity

"Purity" in a peptide COA almost always means area-normalized RP-HPLC purity: the percentage of total peak area in a chromatographic run that belongs to your target compound, versus everything else — truncated sequences, deletion products, diastereomers, and other synthesis byproducts that come along for the ride in solid-phase peptide synthesis.

How RP-HPLC actually separates impurities

Reverse-phase HPLC pushes your sample through a column packed with a hydrophobic stationary phase. Compounds elute at different times based on hydrophobicity — small differences in sequence length or side-chain composition shift retention time enough to separate the target peptide from near-identical byproducts that synthesis inevitably produces. Each peak's area, relative to the total, becomes the purity calculation.

What mass spec adds

HPLC alone tells you how clean the sample is relative to itself — it doesn't confirm what the major peak actually is. Mass spectrometry measures the molecular weight of the dominant species and compares it to the calculated mass of your target sequence. A 99% HPLC purity paired with a mass spec mismatch means you have a very clean sample of the wrong peptide. Identity and purity are two different questions and a real COA answers both.

Why ≥98% is the line

Below roughly 98%, byproduct concentration becomes high enough to meaningfully interfere with reproducibility in sensitive assays. The exact threshold researchers want varies by application, but ≥98% has become the de facto floor for research-grade peptide material because it represents a meaningful inflection point — below it, batch-to-batch variability in byproduct composition starts to matter more.

Beyond the headline number

Purity percentage doesn't capture everything. Residual trifluoroacetic acid (TFA) from synthesis cleanup, residual solvents, and heavy metal content are separate measurements that affect both compound behavior and sample safety in a lab setting. A complete COA reports these alongside the purity figure — not instead of it.

Why lyophilization buys you time

Freeze-drying removes the water that drives most degradation pathways, which is why lyophilized peptides are dramatically more stable than reconstituted solutions. But "more stable" isn't "indestructible" — temperature excursions during shipping and improper storage on receipt can erode that advantage before you ever open the vial.

On receipt

Inspect the vial immediately. Check for a collapsed or shrunken cake (a sign of a temperature excursion during transit), cracked seals, or visible discoloration. Check shipment packaging for ice pack condition if cold-chain was used — partially melted ice packs on arrival are worth noting, even if the product looks fine.

Refrigeration vs. freezing

For short-term use (days to a few weeks), 2–8°C refrigeration is generally adequate. For anything longer, −20°C or colder is the better call. The decision isn't really about which is "better" in the abstract — it's about how often you're going to be opening that vial and how long the material needs to last.

Avoid frost-free freezers for long-term storage. Frost-free units cycle through periodic warming phases to prevent ice buildup — which means your "−20°C" sample is actually swinging through a temperature range multiple times a day. A manual-defrost freezer or dedicated lab freezer holds a stable temperature; a frost-free kitchen-style freezer does not.

Contamination prevention

Use sterile technique when opening vials, even for in-vitro work. Avoid touching the rubber septum with bare hands. If a vial will be accessed multiple times, consider single-use aliquoting on first opening rather than repeatedly re-entering the same stock vial — every entry is a contamination opportunity and a freeze-thaw event if it goes back in the freezer.

Complete workflow

• On arrival: inspect cake integrity and packaging condition, log receipt date.
• Initial storage: move to appropriate temperature immediately — don't let it sit at room temperature "for a bit."
• First opening: equilibrate to room temp, open with sterile technique, aliquot if multi-use.
• Ongoing storage: manual-defrost freezer, amber container, desiccant where possible.
• Periodic check: re-verify purity on long-running studies.

The quality hierarchy nobody tells you about

Much of this market traces back to overseas synthesis channels. What changes between a cheap vial and an expensive vial is often the wrapper around it: documentation, batch consistency, delivery accountability, and whether the seller will tell you where the product came from.

Documentation is the foundation

A real supplier can tell you, for any given vial, which production lot it came from, when that lot was tested, and by whom. A reseller relabeling generic stock under a private brand usually can't — because they don't have lot-level traceability back to synthesis, they have a pallet.

Batch consistency is the reproducibility standard

If you're running comparative work across time, you need batch-to-batch consistency, not just a good result once. That means a seller should be clear about whether documentation is current for the lot being sold, instead of recycling one old COA for a year of restocked inventory. If there is no clear answer, that is the answer.

Testing methodology and what to actually check

HPLC purity and mass spec identity confirmation, from an independent lab, per batch — that's the floor. Beyond that, look for residual solvent and heavy metal screening, which catches synthesis byproducts that a purity percentage alone won't flag.

Supplier transparency: the real trust standard

This is where most of the market fails. US resellers mark up the exact same Chinese-synthesized product 300–500% while implying it's "pharmaceutical grade" domestic manufacturing — language chosen specifically to obscure where the product actually comes from. On the other end, unvetted gray-market direct sellers are honest about sourcing but offer zero testing accountability, so the savings can come with real risk.

A supplier worth using should tell you plainly where the product is made, whether current documentation is available, and what is still pending — before you pay, not after.

What this means for your research

Quality standards aren't just about getting a clean compound once — they're about whether you can trust that the next vial you order is the same as the last one. Documentation completeness, batch consistency, and supplier transparency are the three things that actually predict whether a source will hold up over a multi-month study.